Climb Bio's total assets for Q1 2026 were $152.37M, a decrease of -9.16% from the previous quarter. CLYM total liabilities were $4.29M for the fiscal quarter, a -41.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.